122 related articles for article (PubMed ID: 8203922)
1. [DNA content analysis and detection of c-myc and p53 products using flow cytometry in resected lung cancer cases].
Chiba W; Sawai S; Ikeda S; Morimoto K; Wazawa H; Hanawa T; Yamashita N; Matsui T; Hatakenaka R; Matsubara Y
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():108-16. PubMed ID: 8203922
[TBL] [Abstract][Full Text] [Related]
2. [Positive expression of c-myc and p53 products in two cases of pulmonary sclerosing hemangioma].
Chiba W; Sawai S; Yasuda Y; Wazawa H; Matsubara Y; Ikeda S
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33(12):1348-54. PubMed ID: 8821986
[TBL] [Abstract][Full Text] [Related]
3. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
[TBL] [Abstract][Full Text] [Related]
5. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
Volm M; Efferth T; Mattern J
Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
[TBL] [Abstract][Full Text] [Related]
6. Relationship of p53 alteration and myc family gene overexpression with the clinical characteristics of lung cancer.
Bai L; Sun Y; Li S
Chin Med J (Engl); 1997 Apr; 110(4):250-4. PubMed ID: 9594222
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].
Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric quantitation of C-myc and P53 proteins in bovine papillomavirus type 1-transformed primary mouse fibroblasts.
Agrawal RS; Agrawal YP; Mäntyjärvi RA
Cytometry; 1994 Nov; 17(3):237-45. PubMed ID: 7851159
[TBL] [Abstract][Full Text] [Related]
11. [Detection of intratumoral DNA heterogeneity in primary lung cancer using a multiple sampling method].
Mizobuchi K; Fujita Y; Hashikura H; Arimoto T; Nakagaki Y; Goto T; Fujii T; Iwasaki Y; Nakamura T; Nakagawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Oct; 32(10):963-9. PubMed ID: 7844914
[TBL] [Abstract][Full Text] [Related]
12. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between expression of c-myc and p53 in liposarcoma].
Wang YL; Qiu JS; Xiong M
Ai Zheng; 2002 Jan; 21(1):63-7. PubMed ID: 12500400
[TBL] [Abstract][Full Text] [Related]
14. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
15. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
[TBL] [Abstract][Full Text] [Related]
16. [Flow cytometric analysis of DNA content in lung cancer].
Liu GX
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Oct; 15(5):290-2, 320. PubMed ID: 1339110
[TBL] [Abstract][Full Text] [Related]
17. [Studies on genes associated with biologic behavior in human lung cancer].
Bai L; Sun Y; Li S
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):23-5. PubMed ID: 11263295
[TBL] [Abstract][Full Text] [Related]
18. [Detection of loss of heterozygosity by microsatellite probe and DNA content analysis].
Chiba W; Sawai S; Ikeda S; Kinoshita M; Hatama T; Shin S; Fujimoto T; Miyajima S; Wazawa H; Hanawa T
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():158-63. PubMed ID: 7611781
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of p53 expression and DNA ploidy pattern in esophageal cancer].
Naitoh H; Kawaguchi A; Shibata J; Umeda T; Kodama M; Hattori T
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():110-4. PubMed ID: 7611771
[TBL] [Abstract][Full Text] [Related]
20. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]